- Home
- GLPG vs PGNY Comparison
GLPG vs PGNY Comparison
Compare GLPG & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPG
- PGNY
- Stock Information
- Founded
- GLPG 1999
- PGNY 2008
- Country
- GLPG Belgium
- PGNY United States
- Employees
- GLPG N/A
- PGNY N/A
- Industry
- GLPG Biotechnology: Pharmaceutical Preparations
- PGNY Misc Health and Biotechnology Services
- Sector
- GLPG Health Care
- PGNY Health Care
- Exchange
- GLPG Nasdaq
- PGNY Nasdaq
- Market Cap
- GLPG 1.8B
- PGNY 1.8B
- IPO Year
- GLPG 2005
- PGNY 2019
- Fundamental
- Price
- GLPG $29.92
- PGNY $23.71
- Analyst Decision
- GLPG Sell
- PGNY Buy
- Analyst Count
- GLPG 4
- PGNY 8
- Target Price
- GLPG $25.33
- PGNY $22.86
- AVG Volume (30 Days)
- GLPG 226.8K
- PGNY 1.2M
- Earning Date
- GLPG 07-23-2025
- PGNY 08-07-2025
- Dividend Yield
- GLPG N/A
- PGNY N/A
- EPS Growth
- GLPG N/A
- PGNY N/A
- EPS
- GLPG N/A
- PGNY 0.57
- Revenue
- GLPG $311,493,731.00
- PGNY $1,213,181,000.00
- Revenue This Year
- GLPG $0.78
- PGNY $7.01
- Revenue Next Year
- GLPG N/A
- PGNY $11.53
- P/E Ratio
- GLPG N/A
- PGNY $41.73
- Revenue Growth
- GLPG 18.32
- PGNY 9.46
- 52 Week Low
- GLPG $22.36
- PGNY $13.39
- 52 Week High
- GLPG $31.23
- PGNY $30.42
- Technical
- Relative Strength Index (RSI)
- GLPG 62.12
- PGNY 64.54
- Support Level
- GLPG $28.21
- PGNY $21.09
- Resistance Level
- GLPG $29.23
- PGNY $22.55
- Average True Range (ATR)
- GLPG 0.53
- PGNY 0.88
- MACD
- GLPG 0.09
- PGNY 0.27
- Stochastic Oscillator
- GLPG 93.93
- PGNY 80.23
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.
About PGNY Progyny Inc.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.